Adipose Tissue‐Derived Plasminogen Activator Inhibitor‐1 Function and Regulation

脂肪组织 内分泌学 内科学 脂肪因子 胰岛素抵抗 纤溶酶原激活物抑制剂-1 脂肪细胞 促炎细胞因子 生物 纤溶酶原激活剂 白色脂肪组织 炎症 胰岛素 医学
作者
Hiroshi Kaji
出处
期刊:Comprehensive Physiology [Wiley]
卷期号:: 1873-1896 被引量:76
标识
DOI:10.1002/cphy.c160004
摘要

Adipose tissue has recently been reevaluated as an endocrine organ, and adipose-tissue-derived endocrine factors are termed adipokines. Plasminogen activator inhibitor-1 (PAI-1) is the primary inhibitor of PAs, which convert plasminogen into plasmin, a critical protease involved in fibrinolysis. PAI-1 induces fibrinogenesis by suppressing intravascular and tissue fibrinolysis. Moreover, PAI-1 exerts various cellular effects independently of fibrinolysis. Although PAI-1 is expressed in various tissues, its expression is regulated by numerous growth factors, cytokines, and hormones in a paracrine and endocrine manner. Adipocyte-derived PAI-1, predominantly expressed in visceral fat, is released into the circulation in parallel with increased fat mass, and it functions as a crucial adipokine that negatively affects physiological metabolism and vascular biology. Elevated PAI-1 levels induce insulin resistance and metabolic abnormalities during proinflammatory processes involving several cytokines and chemokines in diabetes. Several studies have indicated that PAI-1 plays crucial roles in insulin actions on liver, muscle, and fat. Accumulated fat and enhanced adipose tissue-derived PAI-1 influence metabolism and vessels in relation to macrophage infiltration, chronic inflammation, and free fatty acid release in obese states. PAI-1-induced fibrinolysis abnormalities are associated with metabolic syndrome, leading to cardiovascular disease through dysregulated vascular coagulation, endothelial dysfunction, and metabolic abnormalities. Adipose tissue-derived PAI-1 is involved in insulin resistance, osteoporosis, and sarcopenia induced by glucocorticoid excess in mice. Moreover, PAI-1 is involved in the other pathological states, such as nonalcoholic fatty liver disease, and cancer. As such, PAI-1 may be exploited as a marker of disease activity as well being a target for clinical drug development. © 2016 American Physiological Society. Compr Physiol 6:1873-1896, 2016.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
nines完成签到 ,获得积分10
1秒前
王翔飞完成签到 ,获得积分10
1秒前
温超完成签到,获得积分10
3秒前
ding应助未来采纳,获得10
4秒前
4秒前
yangching完成签到,获得积分0
4秒前
小年小少发布了新的文献求助10
5秒前
6秒前
6秒前
4123发布了新的文献求助10
6秒前
maox1aoxin应助耕牛热采纳,获得30
6秒前
7秒前
追梦人2016完成签到 ,获得积分10
7秒前
脑洞疼应助tay采纳,获得10
7秒前
hy完成签到 ,获得积分10
8秒前
俏皮碧曼完成签到 ,获得积分10
9秒前
10秒前
落瑾玘发布了新的文献求助10
10秒前
林洁佳发布了新的文献求助10
10秒前
yy发布了新的文献求助10
11秒前
无情颖完成签到 ,获得积分10
11秒前
科研通AI6.2应助缥缈伟祺采纳,获得10
15秒前
16秒前
16秒前
AA完成签到,获得积分20
17秒前
科研通AI6.3应助张瑞采纳,获得10
17秒前
所所应助xxx采纳,获得30
17秒前
20秒前
棠真发布了新的文献求助10
20秒前
20秒前
HH完成签到,获得积分20
21秒前
22秒前
曾经的凌青完成签到,获得积分10
23秒前
HH发布了新的文献求助10
24秒前
26秒前
生物钟发布了新的文献求助10
26秒前
一一应助小年小少采纳,获得10
27秒前
27秒前
jyjy发布了新的文献求助10
28秒前
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 生物化学 化学工程 物理 计算机科学 复合材料 内科学 催化作用 物理化学 光电子学 电极 冶金 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6022745
求助须知:如何正确求助?哪些是违规求助? 7644142
关于积分的说明 16170384
捐赠科研通 5171135
什么是DOI,文献DOI怎么找? 2766988
邀请新用户注册赠送积分活动 1750361
关于科研通互助平台的介绍 1636976